MediPal Holdings Corporation
MAHLY · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2023 FY | 3.36T | 212.12B | 48.97B | 38.81B | 184.82 |
| 2024 FY | 3.56T | 246.66B | 47.33B | 41.47B | 195.83 |
| 2025 FY | 3.67T | 255.76B | 55.61B | 40.28B | 193.19 |
| 2026 FY | 4.05T | 262.33B | 56.39B | 45.10B | 218.90 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2023 FY | 1.70T | 1.02T | 193.56B | 7.38B | 561.36B |
| 2024 FY | 1.80T | 1.06T | 230.15B | 1.46B | 600.35B |
| 2025 FY | 1.82T | 1.07T | 261.41B | 27.91M | 619.56B |
| 2026 FY | 1.93T | 1.13T | 290.33B | — | 655.00B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2023 FY | 16.15B | -13.50B | 2.64B | -9.66B | -66.89B |
| 2024 FY | 61.84B | -19.40B | 42.45B | -11.18B | 34.52B |
| 2025 FY | 60.56B | -12.43B | 48.13B | -12.54B | 31.25B |
| 2026 FY | 49.36B | -7.02B | 42.34B | -14.02B | 13.23B |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2023 FY | 365.07B | 178.89B | — | — | — |
| 2024 FY | 496.18B | 267.49B | — | — | — |
| 2025 FY | 504.90B | 243.52B | — | — | — |
| 2026 FY | 577.49B | 287.16B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 Q1 | 945.16B | 64.68B | 14.05B | 9.59B | 46.17 |
| 2026 Q2 | 969.01B | 63.32B | 11.22B | 12.72B | 62.00 |
| 2026 Q3 | 1.03T | 66.52B | 18.43B | 15.60B | 76.03 |
| 2026 Q4 | 922.33B | 59.59B | 10.18B | 5.21B | 25.56 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2026 Q1 | 1.85T | 1.09T | 246.03B | 268.94M | 616.58B |
| 2026 Q2 | 1.91T | 1.14T | 276.63B | 40.09B | 623.68B |
| 2026 Q3 | 2.02T | 1.24T | 276.06B | 45.15B | 641.64B |
| 2026 Q4 | 1.93T | 1.13T | 290.33B | — | 655.00B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2026 Q1 | — | — | — | — | — |
| 2026 Q2 | — | — | — | — | — |
| 2026 Q3 | — | — | — | — | — |
| 2026 Q4 | — | — | — | — | — |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2026 Q1 | 478.59B | 232.83B | — | — | — |
| 2026 Q2 | 559.05B | 322.50B | — | — | — |
| 2026 Q3 | 576.15B | 345.24B | — | — | — |
| 2026 Q4 | 570.16B | 279.83B | — | — | — |